0001209191-22-036297.txt : 20220613
0001209191-22-036297.hdr.sgml : 20220613
20220613161742
ACCESSION NUMBER: 0001209191-22-036297
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220609
FILED AS OF DATE: 20220613
DATE AS OF CHANGE: 20220613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eichenfield Lawrence
CENTRAL INDEX KEY: 0001814892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38529
FILM NUMBER: 221011824
MAIL ADDRESS:
STREET 1: C/O FORTE BIOSCIENCES, INC.
STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660334
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463137900
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
BUSINESS PHONE: 484-453-3300
MAIL ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-09
0
0001660334
Verrica Pharmaceuticals Inc.
VRCA
0001814892
Eichenfield Lawrence
C/O VERRICA PHARMACEUTICALS INC.
44 WEST GAY STREET, SUITE 400
WEST CHESTER
PA
19380
1
0
0
0
Stock Option (right to buy)
2.15
2022-06-09
4
A
0
10384
0.00
A
2032-06-08
Common Stock
10384
10384
D
The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 9, 2022 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.
/s/ Mark Ballantyne, Attorney-in-Fact
2022-06-13